Edition:
United Kingdom

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.30USD
18 Oct 2018
Change (% chg)

$-0.12 (-2.21%)
Prev Close
$5.42
Open
$5.48
Day's High
$5.48
Day's Low
$5.09
Volume
56,005
Avg. Vol
119,020
52-wk High
$9.69
52-wk Low
$4.44

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.12 December 19 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 3 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.57 1.57 1.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 7.51 13.40 4.60 0.00
Quarter Ending Mar-19 1 5.80 5.80 5.80 --
Year Ending Dec-18 5 30.74 41.60 24.80 2.70
Year Ending Dec-19 5 22.57 31.00 12.00 0.00
Earnings (per share)
Quarter Ending Dec-18 5 -0.12 -0.03 -0.17 -0.21
Quarter Ending Mar-19 1 -0.20 -0.20 -0.20 --
Year Ending Dec-18 5 -0.46 -0.23 -0.56 -0.86
Year Ending Dec-19 5 -0.75 -0.63 -0.95 -0.90

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 12.71 11.69 1.02 8.01
Quarter Ending Mar-18 10.83 4.15 6.68 61.65
Quarter Ending Dec-17 6.77 18.15 11.38 168.12
Quarter Ending Sep-17 1.05 3.93 2.88 274.00
Quarter Ending Jun-17 2.87 1.85 1.01 35.36

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 7.51 7.51 7.51 7.51 0.00
Quarter Ending Mar-19 5.80 5.80 5.80 5.80 --
Year Ending Dec-18 30.74 30.74 30.74 30.74 2.70
Year Ending Dec-19 22.57 22.57 22.57 25.48 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings